Fixes Book Closure for Dividend & AGM
Neuland Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 26, 2013 to August 02, 2013 (both days inclusive) for the purpose of Payment of Dividend & 29th Annual General Meeting (AGM) of the Company to be held on August 02, 2013. Updates
Neuland Laboratories Ltd has informed BSE that the Company has entered into an agreement with Concept Public Relation India Limited for providing strategic communication services which include advertising and publicity. The Company has received the following confirmation from them in providing communication services to Neuland Laboratories Limited:... Board recommends Dividend
Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2013, inter alia, has:1. Recommended payment of dividend of Rs. 1.20 per share of a face value of Rs. 10 each, subject to the approval of Bankers and shareholders of the Company.2. Approved reappointment of Mr. D. Sucheth Rao, as the Whole Time Director and Chief Executive Officer of the Company for a period of (5) Five... Financial Results for March 31, 2013 (Audited)
Neuland Laboratories Ltd has informed BSE about the Financial Results for the period ended March 31, 2013. Board to consider Dividend
Neuland Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 10, 2013, inter alia, to consider and take on record the audited financial results of the Company for the year ended March 31, 2013 and to consider and recommend dividend, if any. Neuland Labs Strengthens Commitment to Japanese Market with New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
Neuland Laboratories Ltd has informed BSE regarding a Press Release dated March 12, 2013, titled "Neuland Labs Strengthens Commitment to Japanese Market with New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation" Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Financial Results & Limited Review for Dec 31, 2012
Neuland Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012. Updates
Neuland Laboratories Ltd has informed BSE regarding "Transfer by way of Sale or long term lease or license of all or a part of Contract Research Services and Peptides Research Business of the Company".